Literature DB >> 30943019

YTHDF1 Control of Dendritic Cell Cross-Priming as a Possible Target of Cancer Immunotherapy.

Daniel J Kim1, Akiko Iwasaki1,2,3.   

Abstract

Entities:  

Year:  2019        PMID： 30943019     DOI： 10.1021/acs.biochem.9b00200

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  3 in total

Review 1.  N6-methyladenine RNA modification and cancer.

Authors:  Jun Yang; Junwen Chen; Xiang Fei; Xia Wang; Kefeng Wang
Journal:  Oncol Lett       Date:  2020-06-16       Impact factor: 2.967

Review 2.  Cross-presentation of exogenous antigens on MHC I molecules.

Authors:  Jeff D Colbert; Freidrich M Cruz; Kenneth L Rock
Journal:  Curr Opin Immunol       Date:  2020-01-09       Impact factor: 7.486

3.  Leishmania amazonensis Subverts the Transcription Factor Landscape in Dendritic Cells to Avoid Inflammasome Activation and Stall Maturation.

Authors:  Hervé Lecoeur; Thibault Rosazza; Kossiwa Kokou; Hugo Varet; Jean-Yves Coppée; Arezou Lari; Pierre-Henri Commère; Robert Weil; Guangxun Meng; Genevieve Milon; Gerald F Späth; Eric Prina
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.